文献速递心外重症与机械循环支持

术前房颤对长期左心室辅助装置治疗中血栓栓塞事件与泵血栓的影响

Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

结果显示两组间泵血栓(P=0.129)和血栓栓塞事件(P=0.163)累积发生率均无显著差异,多因素分析中术前窦性心律对无事件生存无影响(HR 0.86,95%CI 0.68-1.1;P=0.19)。

要点

  • 术前房颤与窦性心律患者LVAD术后的泵血栓和血栓栓塞事件发生率无显著差异。
  • 术前心律状态不影响LVAD患者的无事件生存。
  • 房颤患者LVAD植入时行迷宫手术、导管消融或左心耳封堵对泵血栓和血栓栓塞的预防作用存疑。

核心结论

  • 术前心律对生存、泵血栓和血栓栓塞事件无影响,尽管房颤组与窦性心律组术前危险因素特征不同。

研究设计与样本

  • 回顾性队列研究,纳入2006至2015年单中心连续植入HeartMate II(n=195;25.4%)和HeartWare HVAD(n=574;74.6%)的患者,仅纳入视觉确认的泵血栓,血栓栓塞事件按INTERMACS定义。

主要发现

  • 窦性心律组泵血栓1年累积发生率2.5%(95%CI 0.3-4.7%),2年5.7%(95%CI 2.2-9.2%);房颤组分别为4.9%(95%CI 3.0-6.7%)和7.8%(95%CI 5.4-10.2%)(P=0.129)。
  • 窦性心律组血栓栓塞事件1年累积发生率4.4%(95%CI 1.6-7.2%),2年6.3%(95%CI 2.8-9.8%),中位支持时间214天(范围120-768);房颤组分别为8.4%(95%CI 6.0-10.7%)和10.7%(95%CI 8.0-13.4%),中位支持时间116天(范围37-375),P=0.163。
  • 多因素分析中,术前窦性心律对无事件生存无影响(HR 0.86,95%CI 0.68-1.1;P=0.19)。

临床怎么用

  • 对于LVAD候选患者,术前房颤不应被视为泵血栓或血栓栓塞事件的独立危险因素而改变器械选择或抗栓策略。
  • 房颤患者LVAD植入时常规行迷宫手术、导管消融或左心耳封堵以预防泵血栓和血栓栓塞事件的必要性存疑。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pump thrombosis (PT) and thromboembolic events (TEs) remain major adverse events in left ventricular assist device (LVAD) therapy at an annual rate of 6-8% supported with the HeartWare HVAD and HeartMate II. PT and TEs are multifactorial events. Understanding the predisposing risk factors for PT and TE is paramount to define preventive strategies. Preoperative atrial fibrillation (AF) is considered a significant and potentially modifiable risk factor. This study investigates whether LVAD patients with AF exhibit a higher rate of PT and TE than those in sinus rhythm (SR). METHODS: We evaluated medical records of consecutive patients who underwent implantation of the HeartMate II (n = 195; 25.4%) and HeartWare HVAD (n = 574; 74.6%) at our institution between 2006 and 2015. Only visually confirmed PT was included in the study. TE was defined as any peripheral embolism or cerebral embolism according to the INTERMACS definitions. RESULTS: SR was documented preoperatively in 211 patients (SR group) and AF in 558 patients (AF group). The median duration of support was 0.78 years in the AF group and 1.03 years in the SR group. The mean age was 60.27 years in the AF group and 52.04 years in the SR group. In the AF group, 83.0% of the patients were male, compared to 77.3% in the SR group. The cumulative incidence of PT in the SR group was 2.5% [95% confidence interval (CI) 0.3-4.7%] after 1 year and 5.7% (95% CI 2.2-9.2%) after 2 years, and in the AF group 4.9% (95% CI 3.0-6.7%) and 7.8% (95% CI 5.4-10.2%), respectively (P = 0.129). TEs were recorded in the SR group in 4.4% (95% CI 1.6-7.2%) after 1 year and in 6.3% (95% CI 2.8-9.8%) after 2 years, and occurred after a median support time of 214 days (range 120-768). In the AF group, the cumulative incidence was 8.4% (95% CI 6.0-10.7%) and 10.7% (95% CI 8.0-13.4%), respectively, after a median support time of 116 days (range 37-375), P-value = 0.163. In the multivariate analysis, event-free survival was not influenced by the preoperative SR [hazard ratio (HR) 0.86, 95% CI 0.68-1.1; P = 0.19]. CONCLUSIONS: Our study showed that the preoperative rhythm has no impact on survival, PT and TEs despite different preoperative risk factor profiles in the AF and SR group. Thus, the effect of a maze procedure, catheter ablation or left atrial appendage closure on PT and TE's for AF patients during LVAD implantation is questionable. However, to obtain a definitive answer, a prospective study would be of value.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pedde D, Soltani S, Stein J, et al. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy. Eur J Cardiothorac Surg. 2020. PMID: 31317177. doi:10.1093/ejcts/ezz201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。